IEQ Capital’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

IEQ Capital’s Portfolio LHDX Stock Details LHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-74,095	Closed	-$8.23K	–	914
2022 Q4	$8.23K	Hold	74,095	–	–	﹤0.01%	811
2022 Q3	$79K	Hold	74,095	–	–	﹤0.01%	809
2022 Q2	$138K	Hold	74,095	–	–	﹤0.01%	755
2022 Q1	$265K	Buy	74,095 +890	+1%	+$4.37K	0.01%	669
2021 Q4	$630K	Buy	73,205 +27,030	+59%	+$172K	0.01%	411
2021 Q3	$351K	Hold	46,175	–	–	0.01%	522
2021 Q2	$307K	Buy	+46,175	New	+$291K	0.01%	456

Other funds holding LHDX

Eclipse Ventures Palo Alto, California $2.57B AUM

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Resolute Advisors San Francisco, California $417M AUM 60.99% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

IEQ Capital's LHDX Position: Q1 2023 in Review

IEQ Capital sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2023, closing a stake of 74,095 shares — an estimated $8.23K sold.

IEQ Capital first reported a position in LHDX in Q2 2021 and held it in 7 quarters. The position peaked at $630K in Q4 2021. 6 funds tracked by Wall St. Rank hold LHDX as of Q1 2023.

IEQ Capital reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
IEQ Capital sold 74,095 Lucira Health, Inc. Common Stock shares in Q1 2023, an estimated $8.23K.
IEQ Capital first reported a position in Lucira Health, Inc. Common Stock in Q2 2021 and held it in 7 quarters.
IEQ Capital's Lucira Health, Inc. Common Stock position peaked at $630K in Q4 2021.
6 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2023.

Based on IEQ Capital's 13F filing for Q1 2023, filed 2 May 2023.